Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union books & textbook
Regulatory Processes for Rare Disease Drugs in the United States and European Union: Flexibilities and Collaborative Opportunities
National Academies of Sciences, Engineering, and Medicine Health and Medicine Division Board on Health Sciences Policy Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union Shore, Carolyn K. Worku, Tequam L. Smith, Carson W. Kahn, Jeffrey P.
National Academies Press /2024-11-30 Paperback / 386 Pages
isbn-10: 0309726557 / isbn-13: 9780309726559
